Cytokeratin immunohistochemistry improves interobserver variability between unskilled pathologists in the evaluation of tumor budding in T1 colorectal cancer. (Q53193786)

From Wikidata

Jump to navigation Jump to search

scientific article published on 11 January 2016

Language	Label	Description	Also known as
English	Cytokeratin immunohistochemistry improves interobserver variability between unskilled pathologists in the evaluation of tumor budding in T1 colorectal cancer.	scientific article published on 11 January 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26753834

Cytokeratin immunohistochemistry improves interobserver variability between unskilled pathologists in the evaluation of tumor budding in T1 colorectal cancer. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26753834

colorectal cancer

1 reference

based on heuristic

inferred from title

immunohistochemistry

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26753834%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Keita Kai

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26753834%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Shinichi Aishima

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26753834%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Yukari Takase

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26753834%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Kazuyoshi Uchihashi

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26753834%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Masanori Masuda

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26753834%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Aki Nishijima-Matsunobu

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26753834%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Mihoko Yamamoto

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26753834%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Kousuke Ide

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26753834%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Atsushi Nakayama

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26753834%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Makiko Yamasaki

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26753834%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Shuji Toda

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26753834%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

11 January 2016

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/26753834

Pathology International

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26753834%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

66

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26753834%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26753834%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

75-82

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26753834%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Tumor budding is an independent adverse prognostic factor in pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1111%2FPIN.12374

21 January 2018

Tumor budding and dedifferentiation in gallbladder carcinoma: potential for the prognostic factors in T2 lesions

1 reference

https://api.crossref.org/works/10.1111%2FPIN.12374

21 January 2018

Tumor dedifferentiation: an important step in tumor invasion.

1 reference

https://api.crossref.org/works/10.1111%2FPIN.12374

21 January 2018

Tumour budding in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FPIN.12374

21 January 2018

An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer

1 reference

https://api.crossref.org/works/10.1111%2FPIN.12374

21 January 2018

Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer.

1 reference

https://api.crossref.org/works/10.1111%2FPIN.12374

21 January 2018

A new prognostic staging system for rectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FPIN.12374

21 January 2018

Risk factors for an adverse outcome in early invasive colorectal carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FPIN.12374

21 January 2018

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer.

1 reference

https://api.crossref.org/works/10.1111%2FPIN.12374

21 January 2018

Tumor budding in colorectal carcinoma: time to take notice

1 reference

https://api.crossref.org/works/10.1111%2FPIN.12374

21 January 2018

Differential prognostic significance of morphologic invasive markers in colorectal cancer: tumor budding and cytoplasmic podia

1 reference

https://api.crossref.org/works/10.1111%2FPIN.12374

21 January 2018

Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2.

1 reference

https://api.crossref.org/works/10.1111%2FPIN.12374

21 January 2018

CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a 'pro-/anti-tumour' approach to tumour host interaction in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1111%2FPIN.12374

21 January 2018

Evaluation of venous invasion by Elastica van Gieson stain and tumor budding predicts local and distant metastases in patients with T1 stage colorectal cancer.

1 reference

https://api.crossref.org/works/10.1111%2FPIN.12374

21 January 2018

Histopathologic determinants of regional lymph node metastasis in early colorectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FPIN.12374

21 January 2018

Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1111%2FPIN.12374

21 January 2018

High-degree tumor budding and podia-formation in sporadic colorectal carcinomas with K-ras gene mutations.

1 reference

https://api.crossref.org/works/10.1111%2FPIN.12374

21 January 2018

Tumor budding as a prognostic marker in stage-III rectal carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FPIN.12374

21 January 2018

Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FPIN.12374

21 January 2018

Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy

1 reference

https://api.crossref.org/works/10.1111%2FPIN.12374

21 January 2018

Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FPIN.12374

21 January 2018

Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FPIN.12374

21 January 2018

Tumor budding in colorectal cancer revisited: results of a multicenter interobserver study

1 reference

https://api.crossref.org/works/10.1111%2FPIN.12374

21 January 2018

Tumour budding and a low host inflammatory response are associated with a poor prognosis in oesophageal and gastro-oesophageal junction cancers

1 reference

https://api.crossref.org/works/10.1111%2FPIN.12374

21 January 2018

Identifiers

10.1111/PIN.12374

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26753834%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26753834%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53193786&oldid=1292072374"